Byetta
World of DTC Marketing

Data Wars

Jul/11/2007 03:43 Filed in: DTC Environment
Newer diabetes medicines from makers including Merck & Co. and Eli Lilly & Co. work no better than older, cheaper drugs, researchers said. Here we go again! The merry-go-round continues as the data wars spread to a wider battlefield. Read More...

Tags:

|

Building a blockbuster without DTC

Jun/26/2007 06:34 Filed in: DTC Environment
22diabetes_600x262
With the annual market for diabetes drugs expected to reach at least $25 billion worldwide by 2011, up from $15 billion today, drug makers have been investing heavily in new approaches to treating diabetes. With the recent troubles of oral agents injectable medications are now gaining more attention including Byetta which has quietly seen its market share increase without substantial DTC because of world of mouth about one of Byetta's side effects...weight loss. Read More...

Tags:

|